These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33378104)

  • 1. Exploring Viral Interference Using Peptides: Molecular Determinants of HIV-1 Inhibition by a Peptide Derived from Human Pegivirus-1 Envelope Protein E2.
    Hoffmann R; Ruegamer T; Schaubächer J; Rohrhofer A; Kirmeß P; Fiebig KM; Schmidt B; Eichler J
    ChemMedChem; 2021 Apr; 16(8):1290-1296. PubMed ID: 33378104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 fusion is blocked through binding of GB Virus C E2-derived peptides to the HIV-1 gp41 disulfide loop [corrected].
    Eissmann K; Mueller S; Sticht H; Jung S; Zou P; Jiang S; Gross A; Eichler J; Fleckenstein B; Reil H
    PLoS One; 2013; 8(1):e54452. PubMed ID: 23349893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor.
    Cormier EG; Dragic T
    J Virol; 2002 Sep; 76(17):8953-7. PubMed ID: 12163614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1-induced fusion and entry.
    Fantini J; Hammache D; Delézay O; Yahi N; André-Barrès C; Rico-Lattes I; Lattes A
    J Biol Chem; 1997 Mar; 272(11):7245-52. PubMed ID: 9054420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the HIV-1 gp120 viral protein V3 loop with bacterial lipopolysaccharide: a pattern recognition inhibition.
    Majerle A; Pristovsek P; Mancek-Keber M; Jerala R
    J Biol Chem; 2011 Jul; 286(29):26228-37. PubMed ID: 21636577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV-1 infection by human pegivirus type 1-derived peptides is affected by human pegivirus type 1 genotype and HIV-1 coreceptor tropism.
    Ruegamer T; Hoffmann R; Rohrhofer A; Audebert F; Salzberger B; Korn K; Schuster P; Eichler J; Schmidt B
    AIDS; 2018 Sep; 32(14):1951-1957. PubMed ID: 29912064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding.
    Tugarinov V; Zvi A; Levy R; Hayek Y; Matsushita S; Anglister J
    Structure; 2000 Apr; 8(4):385-95. PubMed ID: 10801487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.
    Labrosse B; Treboute C; Brelot A; Alizon M
    J Virol; 2001 Jun; 75(12):5457-64. PubMed ID: 11356952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.
    Neurath AR; Strick N; Debnath AK
    J Mol Recognit; 1995; 8(6):345-57. PubMed ID: 9052975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A post-CD4-binding step involving interaction of the V3 region of viral gp120 with host cell surface glycosphingolipids is common to entry and infection by diverse HIV-1 strains.
    Nehete PN; Vela EM; Hossain MM; Sarkar AK; Yahi N; Fantini J; Sastry KJ
    Antiviral Res; 2002 Dec; 56(3):233-51. PubMed ID: 12406507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of anti-HIV activity of succinylated human serum albumin.
    Kuipers ME; vd Berg M; Swart PJ; Laman JD; Meijer DK; Koppelman MH; Huisman H
    Biochem Pharmacol; 1999 Apr; 57(8):889-98. PubMed ID: 10086322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The V3 loop of human immunodeficiency virus type-1 envelope protein is a high-affinity ligand for immunophilins present in human blood.
    Endrich MM; Gehring H
    Eur J Biochem; 1998 Mar; 252(3):441-6. PubMed ID: 9546659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition properties of V3-specific antibodies to V3 loop peptides derived from HIV-1 gp120 presented in multiple conformations.
    Huisman JG; Carotenuto A; Labrijn AF; Papavoine CH; Laman JD; Schellekens MM; Koppelman MH; Hilbers CW
    Biochemistry; 2000 Sep; 39(35):10866-76. PubMed ID: 10978173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of gp120 of human immunodeficiency virus by their V3 loop-derived peptides.
    Ling H; Zhang XY; Usami O; Hattori T
    Biochem Biophys Res Commun; 2002 Sep; 297(3):625-31. PubMed ID: 12270140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.
    Verrier F; Borman AM; Brand D; Girard M
    AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the potential regions of Epap-1 that interacts with V3 loop of HIV-1 gp120.
    Bhaskar C; Reddy PS; Chandra KS; Sabde S; Mitra D; Kondapi AK
    Biochim Biophys Acta; 2013 Apr; 1834(4):780-90. PubMed ID: 23360764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
    Moseri A; Biron Z; Arshava B; Scherf T; Naider F; Anglister J
    FEBS J; 2015 Dec; 282(24):4643-57. PubMed ID: 26432362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N-terminal of the V3 loop in HIV type 1 gp120 is responsible for its conformation-dependent interaction with cell surface molecules.
    Ling H; Usami O; Xiao P; Gu HX; Hattori T
    AIDS Res Hum Retroviruses; 2004 Feb; 20(2):213-8. PubMed ID: 15018709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.